approval
saveSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 0 trial initiationWashington University School of Medicine — asciminib hydrochloride (Phase 0 Trial Initiation)Apr 30, 2026 · 157d ago
- phase 2 initiationNovartis AG — asciminib hydrochloride (Phase II Trial Initiation)Apr 25, 2026 · 162d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 2, 2025 · 367d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 29, 2024 · 705d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 29, 2024 · 705d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalAug 7, 2024 · 788d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalJun 18, 2024 · 838d ago
- approvalSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalNov 8, 2023 · 1061d ago
same company · ±60 days · 6
- approvalatrasentan hydrochloride: VANRAFIA (ATRASENTAN HYDROCHLORIDE) — FDA approvalOct 20, 2025
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalJan 14, 2026
- approvalasciminib hydrochloride: SCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalOct 2, 2025
- approvalremibrutinib: RHAPSIDO (REMIBRUTINIB) — FDA approvalSep 30, 2025
- approvalcarbamazepine ER: TEGRETOL (CARBAMAZEPINE) — FDA approvalSep 30, 2025
- approvalcarbamazepine ER: TEGRETOL (CARBAMAZEPINE) — FDA approvalSep 30, 2025
🐶 often sniffed alongside
top 7- drugSCEMBLIX46 co-mentions · 13 sources
- tagApproval44 co-mentions · 11 sources
- tagSmall Molecule22 co-mentions · 11 sources
- tagOncology3 co-mentions · 2 sources
- company$NVSNOVARTIS AG1 co-mentions · 1 sources
- company$NVSEFNOVARTIS AG1 co-mentions · 1 sources
- companyWashington University School of Medicine1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that